Novel phosphatidylinositol 3-kinase inhibitor NVP-BKM120 induces apoptosis in myeloma cells and shows synergistic anti-myeloma activity with dexamethasone

NVP-BKM120 is a novel phosphatidylinositol 3-kinase (PI3K) inhibitor and is currently being investigated in phase I clinical trials in solid tumors. This study aimed to evaluate the therapeutic efficacy of BKM120 in multiple myeloma (MM). BKM120 induces cell growth inhibition and apoptosis in both M...

Полное описание

Сохранить в:
Библиографические подробности
Главные авторы: Zheng, Yuhuan, Yang, Jing, Qian, Jianfei, Zhang, Liang, Lu, Yong, Li, Haiyan, Lin, Heather, Lan, Yongsheng, Liu, Zhiqiang, He, Jin, Hong, Sungyoul, Thomas, Sheeba, Shah, Jatin, Baladandayuthapani, Veera, Kwak, Larry W., Yi, Qing
Формат: Artigo
Язык:Inglês
Опубликовано: 2011
Предметы:
Article
Online-ссылка:https://ncbi.nlm.nih.gov/pmc/articles/PMC4212830/
https://ncbi.nlm.nih.gov/pubmed/22207485
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s00109-011-0849-9
Метки: Добавить метку
Нет меток, Требуется 1-ая метка записи!

Схожие документы